Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 5/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.46 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.45 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | NMT2 | O60551 | 1/20 | 0.42 |
| ▸ | NMT1 | P30419 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30984644 | 1.00 | TERT (0.50) | TERTPTGS1GSTK1MMP2GNAI3 | |
| SCHEMBL29486323 | 1.00 | TERT (0.50) | TERTPTGS1GSTK1MMP2GNAI3 | |
| SCHEMBL18234163 | 0.91 | NMT1 (0.51) | TERTPTGS1GSTK1MMP2GLO1 | |
| SCHEMBL29369655 | 0.91 | PTGS1 (0.54) | TERTPTGS1GSTK1MMP2GNAI3 | |
| SCHEMBL23968643 | 0.91 | PTGS1 (0.54) | TERTPTGS1GSTK1MMP2GNAI3 | |
| SCHEMBL30064268 | 0.90 | FOLH1 (0.48) | TERTPTGS1GSTK1MMP2GLO1 | |
| SCHEMBL18234267 | 0.90 | NMT1 (0.53) | TERTPTGS1GSTK1GLO1NMT2 | |
| SCHEMBL29397470 | 0.90 | GSR (0.47) | TERTPTGS1GSTK1MMP2GNAI3 | |
| SCHEMBL29945241 | 0.90 | TERT (0.46) | TERTPTGS1GSTK1MMP2GNAI3 | |
| SCHEMBL29569342 | 0.89 | PTGS1 (0.43) | TERTPTGS1GSTK1MMP2GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378288-B2 | Multimeric bicyclic peptide ligands | BICYCLETX LIMITED (GB) | 2025-08-05 | — | — | US | disclosed |
| US-20230220008-A1 | MULTIMERIC BICYCLIC PEPTIDE LIGANDS | BICYCLETX LIMITED (GB) | 2023-07-13 | — | — | US | disclosed |
| US-11542304-B2 | Multimeric bicyclic peptide ligands | BICYCLETX LIMITED | 2023-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378288-B2 | Multimeric bicyclic peptide ligands | CD40, TNFSF11, TNFRSF9 | TERT 2447/4885PTGS1 4264/4885GSTK1 1725/4885 |
| US-11542304-B2 | Multimeric bicyclic peptide ligands | CD40, TNFSF11, TNFRSF9 | TERT 2447/4885PTGS1 4264/4885GSTK1 1725/4885 |
| US-20230220008-A1 | MULTIMERIC BICYCLIC PEPTIDE LIGANDS | CD40, TNFSF11, TNFRSF9 | TERT 2447/4885PTGS1 4264/4885GSTK1 1725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.